Stanford bioengineer Kwabena Boahen is on a quest to build computers that function like the brain, which could be the solution for the expense and environmental impact of AI’s high demand for computing power.
Male authors of biomedical research papers are named as inventors on patents more frequently than female authors, according to a study by a team of law and medical students.
A low-cost, recyclable powder can kill thousands of waterborne bacteria per second when exposed to sunlight. Stanford and SLAC scientists say the ultrafast disinfectant could be a revolutionary advance for 2 billion people worldwide without access to safe drinking water.
As public control of U.S. hospitals declines, a study by SIEPR’s Mark Duggan shows how privatization improves profitability but reduces access for the most vulnerable patients.
Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo “party drugs” as a promising new frontier in psychiatric medicine.
Many Americans are raising complicated concerns about the causes and solutions to gun violence. Stanford scholars offer their research findings from a variety of perspectives.
Watch a discussion of the promise and pitfalls of using AI to bring life-saving drugs to market, including a look at justice and equity in drug research and access.
From teaching the fine art of the spinal tap to gamifying at-home physical therapy for stroke survivors, creative uses of virtual and augmented reality technology in medicine were on display at an open-house held in December at the Wu Tsai Neurosciences Institute.
A new three-quarter sequence of courses provides insights from scholars around the nation on research related to race in the fields of science, technology and medicine, as well as their own lived experiences.
